{"pmid":32416598,"title":"SARS-CoV-2 detection by direct rRT-PCR without RNA extraction.","text":["SARS-CoV-2 detection by direct rRT-PCR without RNA extraction.","Rapid and reliable screening of SARS-CoV-2 is fundamental to assess viral spread and limit the pandemic we are facing. In this study, we compared direct rRT-PCR method (without RNA extraction) using SeeGene AllplexTM 2019-nCoV rRT-PCR with the RealStar(R) SARS-CoV-2 rRT-PCR kit (Altona Diagnostics). Furthermore, we assessed the impact of swab storage media composition on PCR efficiency. We show that SeeGene and Altona's assays provide similar efficiency. Importantly, we provide evidence that RNA extraction can be successfully bypassed when samples are stored in UTM medium or in molecular water but not when samples are stored in saline solution and in Hanks medium.","J Clin Virol","Merindol, Natacha","Pepin, Genevieve","Marchand, Caroline","Rheault, Marylene","Peterson, Christine","Poirier, Andre","Houle, Claudia","Germain, Hugo","Danylo, Alexis","32416598"],"abstract":["Rapid and reliable screening of SARS-CoV-2 is fundamental to assess viral spread and limit the pandemic we are facing. In this study, we compared direct rRT-PCR method (without RNA extraction) using SeeGene AllplexTM 2019-nCoV rRT-PCR with the RealStar(R) SARS-CoV-2 rRT-PCR kit (Altona Diagnostics). Furthermore, we assessed the impact of swab storage media composition on PCR efficiency. We show that SeeGene and Altona's assays provide similar efficiency. Importantly, we provide evidence that RNA extraction can be successfully bypassed when samples are stored in UTM medium or in molecular water but not when samples are stored in saline solution and in Hanks medium."],"journal":"J Clin Virol","authors":["Merindol, Natacha","Pepin, Genevieve","Marchand, Caroline","Rheault, Marylene","Peterson, Christine","Poirier, Andre","Houle, Claudia","Germain, Hugo","Danylo, Alexis"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416598","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jcv.2020.104423","keywords":["covid19","coronavirus","direct rrtpcr","rna extraction","sars-cov-2","virus detection"],"topics":["Diagnosis"],"weight":1,"_version_":1666991242715594752,"score":9.490897,"similar":[{"pmid":32416600,"title":"Comparison of seven commercial RT-PCR diagnostic kits for COVID-19.","text":["Comparison of seven commercial RT-PCR diagnostic kits for COVID-19.","The final months of 2019 witnessed the emergence of a novel coronavirus in the human population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread across the globe and is posing a major burden on society. Measures taken to reduce its spread critically depend on timely and accurate identification of virus-infected individuals by the most sensitive and specific method available, i.e. real-time reverse transcriptase PCR (RT-PCR). Many commercial kits have recently become available, but their performance has not yet been independently assessed. The aim of this study was to compare basic analytical and clinical performance of selected RT-PCR kits from seven different manufacturers (Altona Diagnostics, BGI, CerTest Biotec, KH Medical, PrimerDesign, R-Biopharm AG, and Seegene). We used serial dilutions of viral RNA to establish PCR efficiency and estimate the 95 % limit of detection (LOD95). Furthermore, we ran a panel of SARS-CoV-2-positive clinical samples (n = 13) for a preliminary evaluation of clinical sensitivity. Finally, we used clinical samples positive for non-coronavirus respiratory viral infections (n = 6) and a panel of RNA from related human coronaviruses to evaluate assay specificity. PCR efficiency was >/=96 % for all assays and the estimated LOD95 varied within a 6-fold range. Using clinical samples, we observed some variations in detection rate between kits. Importantly, none of the assays showed cross-reactivity with other respiratory (corona)viruses, except as expected for the SARS-CoV-1 E-gene. We conclude that all RT-PCR kits assessed in this study may be used for routine diagnostics of COVID-19 in patients by experienced molecular diagnostic laboratories.","J Clin Virol","van Kasteren, Puck B","van der Veer, Bas","van den Brink, Sharon","Wijsman, Lisa","de Jonge, Jorgen","van den Brandt, Annemarie","Molenkamp, Richard","Reusken, Chantal B E M","Meijer, Adam","32416600"],"abstract":["The final months of 2019 witnessed the emergence of a novel coronavirus in the human population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread across the globe and is posing a major burden on society. Measures taken to reduce its spread critically depend on timely and accurate identification of virus-infected individuals by the most sensitive and specific method available, i.e. real-time reverse transcriptase PCR (RT-PCR). Many commercial kits have recently become available, but their performance has not yet been independently assessed. The aim of this study was to compare basic analytical and clinical performance of selected RT-PCR kits from seven different manufacturers (Altona Diagnostics, BGI, CerTest Biotec, KH Medical, PrimerDesign, R-Biopharm AG, and Seegene). We used serial dilutions of viral RNA to establish PCR efficiency and estimate the 95 % limit of detection (LOD95). Furthermore, we ran a panel of SARS-CoV-2-positive clinical samples (n = 13) for a preliminary evaluation of clinical sensitivity. Finally, we used clinical samples positive for non-coronavirus respiratory viral infections (n = 6) and a panel of RNA from related human coronaviruses to evaluate assay specificity. PCR efficiency was >/=96 % for all assays and the estimated LOD95 varied within a 6-fold range. Using clinical samples, we observed some variations in detection rate between kits. Importantly, none of the assays showed cross-reactivity with other respiratory (corona)viruses, except as expected for the SARS-CoV-1 E-gene. We conclude that all RT-PCR kits assessed in this study may be used for routine diagnostics of COVID-19 in patients by experienced molecular diagnostic laboratories."],"journal":"J Clin Virol","authors":["van Kasteren, Puck B","van der Veer, Bas","van den Brink, Sharon","Wijsman, Lisa","de Jonge, Jorgen","van den Brandt, Annemarie","Molenkamp, Richard","Reusken, Chantal B E M","Meijer, Adam"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416600","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jcv.2020.104412","keywords":["covid-19","coronavirus","in vitro diagnostics","rt-pcr","sars-cov-2","ncov-2019"],"topics":["Diagnosis"],"weight":1,"_version_":1666991242700914688,"score":412.5746},{"pmid":32341141,"title":"Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR.","text":["Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR.","The global COVID-19 pandemic has resulted in a worldwide shortage of viral transport media and raised questions about specimen stability. The objective of this study was to determine the stability of SARS-CoV-2 virus RNA in specimen transport media under various storage conditions. Transport medium tested included: VCM, UTM(R)-RT, ESwab, M4 and saline (0.9% NaCl). Specimen types tested included Nasopharyngeal/Oropharyngeal (NP/OP) swabs in the above transport media, bronchoalveolar lavage (BAL) and Sputum. A high-titer SARS-CoV-2 remnant patient specimen was spiked into pooled SARS-CoV-2 RNA-negative specimen remnants for the various media types. Aliquots of samples were stored at 18 degrees C to 25 degrees C, 2 degrees C to 8 degrees C and -10 degrees C to -30 degrees C and then tested at time points up to 14 days. Specimens consistently yielded amplifiable RNA with mean Ct differences of <3 over the various conditions assayed, thus supporting the use and transport of alternative collection media and specimen types under a variety of temperature storage conditions.","J Clin Microbiol","Rogers, Amy A","Baumann, Russell E","Borillo, Gwynngelle A","Kagan, Ron M","Batterman, Hollis J","Galdzicka, Marzena","Marlowe, Elizabeth M","32341141"],"abstract":["The global COVID-19 pandemic has resulted in a worldwide shortage of viral transport media and raised questions about specimen stability. The objective of this study was to determine the stability of SARS-CoV-2 virus RNA in specimen transport media under various storage conditions. Transport medium tested included: VCM, UTM(R)-RT, ESwab, M4 and saline (0.9% NaCl). Specimen types tested included Nasopharyngeal/Oropharyngeal (NP/OP) swabs in the above transport media, bronchoalveolar lavage (BAL) and Sputum. A high-titer SARS-CoV-2 remnant patient specimen was spiked into pooled SARS-CoV-2 RNA-negative specimen remnants for the various media types. Aliquots of samples were stored at 18 degrees C to 25 degrees C, 2 degrees C to 8 degrees C and -10 degrees C to -30 degrees C and then tested at time points up to 14 days. Specimens consistently yielded amplifiable RNA with mean Ct differences of <3 over the various conditions assayed, thus supporting the use and transport of alternative collection media and specimen types under a variety of temperature storage conditions."],"journal":"J Clin Microbiol","authors":["Rogers, Amy A","Baumann, Russell E","Borillo, Gwynngelle A","Kagan, Ron M","Batterman, Hollis J","Galdzicka, Marzena","Marlowe, Elizabeth M"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341141","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1128/JCM.00708-20","locations":["UTM(R)-RT"],"e_drugs":["Sodium Chloride"],"topics":["Diagnosis"],"weight":1,"_version_":1666138495100387330,"score":336.67218},{"pmid":32335089,"pmcid":"PMC7179514","title":"Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories.","text":["Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories.","BACKGROUND: The detection of SARS-CoV-2 RNA by real-time reverse transcription-polymerase chain reaction (rRT-PCR) is used to confirm the clinical diagnosis of COVID-19 by molecular diagnostic laboratories. We developed a multiplex rRT-PCR methodology for the detection of SARS-CoV-2 RNA. METHODS: Three genes were used for multiplex rRT-PCR: the Sarbecovirus specific E gene, the SARS-CoV-2 specific N gene, and the human ABL1 gene as an internal control. RESULTS: Good correlation of Cq values was observed between the simplex and multiplex rRT-PCR methodologies. Low copies (<25 copies/reaction) of SARS-CoV-2 RNA were detected by the novel multiplex rRT-PCR method. CONCLUSION: The proposed multiplex rRT-PCR methodology will enable highly sensitive detection of SARS-CoV-2 RNA, reducing reagent use and cost, and time required by clinical laboratory technicians.","Clin Chim Acta","Ishige, Takayuki","Murata, Shota","Taniguchi, Toshibumi","Miyabe, Akiko","Kitamura, Kouichi","Kawasaki, Kenji","Nishimura, Motoi","Igari, Hidetoshi","Matsushita, Kazuyuki","32335089"],"abstract":["BACKGROUND: The detection of SARS-CoV-2 RNA by real-time reverse transcription-polymerase chain reaction (rRT-PCR) is used to confirm the clinical diagnosis of COVID-19 by molecular diagnostic laboratories. We developed a multiplex rRT-PCR methodology for the detection of SARS-CoV-2 RNA. METHODS: Three genes were used for multiplex rRT-PCR: the Sarbecovirus specific E gene, the SARS-CoV-2 specific N gene, and the human ABL1 gene as an internal control. RESULTS: Good correlation of Cq values was observed between the simplex and multiplex rRT-PCR methodologies. Low copies (<25 copies/reaction) of SARS-CoV-2 RNA were detected by the novel multiplex rRT-PCR method. CONCLUSION: The proposed multiplex rRT-PCR methodology will enable highly sensitive detection of SARS-CoV-2 RNA, reducing reagent use and cost, and time required by clinical laboratory technicians."],"journal":"Clin Chim Acta","authors":["Ishige, Takayuki","Murata, Shota","Taniguchi, Toshibumi","Miyabe, Akiko","Kitamura, Kouichi","Kawasaki, Kenji","Nishimura, Motoi","Igari, Hidetoshi","Matsushita, Kazuyuki"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335089","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.cca.2020.04.023","keywords":["covid-19","high-sensitive","molecular diagnosis","multiplex","sars-cov-2","rrt-pcr"],"locations":["Sarbecovirus"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494101094400,"score":323.24484},{"pmid":32405270,"pmcid":"PMC7219422","title":"Detection of SARS-CoV-2 is comparable in clinical samples preserved in saline or viral transport media.","text":["Detection of SARS-CoV-2 is comparable in clinical samples preserved in saline or viral transport media.","As the COVID-19 pandemic sweeps across the world, the availability of viral transport media (VTM) has become severely limited, contributing to delays in diagnosis and rationing of diagnostic testing. Given that SARS-CoV-2 viral RNA has demonstrated stability, we posited that phosphate buffered saline (PBS) may be a viable transport medium, as an alternative to VTM), for clinical qPCR testing. We assessed the intra- and inter-individual reliability of SARS-CoV-2 qPCR in clinical endotracheal secretion samples transported in VTM or PBS, evaluating the stability of the RT-qPCR signal for three viral targets (N gene, ORF1ab, and S gene) when samples were stored in these media at room temperature for up to 18 hours. We report that using PBS as a transport medium has high intra-and inter-individual reliability, maintains viral stability, and is comparable to VTM in the detection of the three SARS-CoV-2 genes through 18 hours of storage. Our study establishes PBS as a clinically useful medium that can be readily deployed for transporting and short-term preservation of specimens containing SARS-CoV-2. Use of PBS as a transport medium has the potential to increase testing capacity for SARS-CoV-2, aiding more widespread screening and early diagnosis of COVID-19.","J Mol Diagn","Radbel, Jared","Jagpal, Sugeet","Roy, Jason","Brooks, Andrew","Tischfield, Jay","Sheldon, Michael","Bixby, Christian","Witt, Dana","Gennaro, Maria Laura","Horton, Daniel B","Barrett, Emily S","Carson, Jeffrey L","Panettieri, Reynold A Jr","Blaser, Martin J","32405270"],"abstract":["As the COVID-19 pandemic sweeps across the world, the availability of viral transport media (VTM) has become severely limited, contributing to delays in diagnosis and rationing of diagnostic testing. Given that SARS-CoV-2 viral RNA has demonstrated stability, we posited that phosphate buffered saline (PBS) may be a viable transport medium, as an alternative to VTM), for clinical qPCR testing. We assessed the intra- and inter-individual reliability of SARS-CoV-2 qPCR in clinical endotracheal secretion samples transported in VTM or PBS, evaluating the stability of the RT-qPCR signal for three viral targets (N gene, ORF1ab, and S gene) when samples were stored in these media at room temperature for up to 18 hours. We report that using PBS as a transport medium has high intra-and inter-individual reliability, maintains viral stability, and is comparable to VTM in the detection of the three SARS-CoV-2 genes through 18 hours of storage. Our study establishes PBS as a clinically useful medium that can be readily deployed for transporting and short-term preservation of specimens containing SARS-CoV-2. Use of PBS as a transport medium has the potential to increase testing capacity for SARS-CoV-2, aiding more widespread screening and early diagnosis of COVID-19."],"journal":"J Mol Diagn","authors":["Radbel, Jared","Jagpal, Sugeet","Roy, Jason","Brooks, Andrew","Tischfield, Jay","Sheldon, Michael","Bixby, Christian","Witt, Dana","Gennaro, Maria Laura","Horton, Daniel B","Barrett, Emily S","Carson, Jeffrey L","Panettieri, Reynold A Jr","Blaser, Martin J"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405270","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jmoldx.2020.04.209","topics":["Diagnosis"],"weight":1,"_version_":1666802845455745024,"score":319.22488},{"pmid":32492531,"title":"Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.","text":["Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.","OBJECTIVES: The gold-standard COVID-19 diagnosis relies on detecting SARS-CoV-2 using RNA purification and one-step retrotranscription and quantitative PCR (RT-qPCR). Based on the urgent need for high-throughput screening, we tested the performance of three alternative, simple and affordable protocols to rapidly detect SARS-CoV-2, bypassing the long and tedious RNA extraction step and reducing the time to viral detection. METHODS: We evaluated three methods based on direct nasopharyngeal swab viral transmission medium (VTM) heating before the RT-qPCR: a) direct without additives; b) in a formamide-EDTA (FAE) buffer, c) in a RNAsnap(TM) buffer. RESULTS: Although with a delay in cycle threshold compared to the gold-standard, we found consistent results in nasopharyngeal swab samples that were subject to a direct 70 degrees C incubation for 10 min. CONCLUSIONS: Our findings provide valuable options to overcome any supply chain issue and help to increase the throughput of diagnostic tests, thereby complementing standard diagnosis.","Int J Infect Dis","Alcoba-Florez, Julia","Gonzalez-Montelongo, Rafaela","Inigo-Campos, Antonio","de Artola, Diego Garcia-Martinez","Gil-Campesino, Helena","The Microbiology Technical Support Team","Ciuffreda, Laura","Valenzuela-Fernandez, Agustin","Flores, Carlos","32492531"],"abstract":["OBJECTIVES: The gold-standard COVID-19 diagnosis relies on detecting SARS-CoV-2 using RNA purification and one-step retrotranscription and quantitative PCR (RT-qPCR). Based on the urgent need for high-throughput screening, we tested the performance of three alternative, simple and affordable protocols to rapidly detect SARS-CoV-2, bypassing the long and tedious RNA extraction step and reducing the time to viral detection. METHODS: We evaluated three methods based on direct nasopharyngeal swab viral transmission medium (VTM) heating before the RT-qPCR: a) direct without additives; b) in a formamide-EDTA (FAE) buffer, c) in a RNAsnap(TM) buffer. RESULTS: Although with a delay in cycle threshold compared to the gold-standard, we found consistent results in nasopharyngeal swab samples that were subject to a direct 70 degrees C incubation for 10 min. CONCLUSIONS: Our findings provide valuable options to overcome any supply chain issue and help to increase the throughput of diagnostic tests, thereby complementing standard diagnosis."],"journal":"Int J Infect Dis","authors":["Alcoba-Florez, Julia","Gonzalez-Montelongo, Rafaela","Inigo-Campos, Antonio","de Artola, Diego Garcia-Martinez","Gil-Campesino, Helena","The Microbiology Technical Support Team","Ciuffreda, Laura","Valenzuela-Fernandez, Agustin","Flores, Carlos"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492531","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.ijid.2020.05.099","keywords":["covid-19","rna extraction","sars-cov-2","diagnosis","fast protocols","sample treatment"],"topics":["Diagnosis"],"weight":1,"_version_":1668623433626288129,"score":313.15277}]}